Protein-binding function of RNA-dependent protein kinase promotes proliferation through TRAF2/RIP1/NF-κB/c-Myc pathway in pancreatic β cells

Molecular Medicine

Volumn 21, Issue , 2015, Pages 154-166

  Gao, LiLi ^a   Tang, Wei ^b   Ding, ZhengZheng ^a   Wang, DingYu ^a   Qi, XiaoQiang ^a   Wu, Hui Wen ^a   Guo, Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGYIN PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MYC PROTEIN; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING SERINE THREONINE PROTEIN KINASE 1; RNA DEPENDENT PROTEIN KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PROTEIN BINDING; PROTEIN KINASE R; RALBP1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; GLUCOLIPITOXICITY; IN VITRO STUDY; INTRACELLULAR SIGNALING; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; ONCOGENE C MYC; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TOXICITY; TRAF2 GENE; TRAF6 GENE; TRANSCRIPTION REGULATION; UBIQUITINATION; UPREGULATION; ANIMAL; CATALYSIS; CELL SURVIVAL; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CATALYSIS; CELL PROLIFERATION; CELL SURVIVAL; EIF-2 KINASE; GENE EXPRESSION REGULATION; GTPASE-ACTIVATING PROTEINS; HUMANS; INSULIN-SECRETING CELLS; MICE; NF-KAPPA B; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84935875147     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2014.00235     Document Type: Article

References (79)

1. Garcia MA, et al. (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70:1032-60.
2. Bennett RL, et al. (2012) The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G(1) arrest. Cell Cycle. 11:407-17.
3. Zhang S, et al. (2014) Activation of the PKR/eIF2alpha signaling cascade inhibits replication of Newcastle disease virus. Virol. J. 11:62.
4. Marchal JA, et al. (2014) The impact of PKR activation: from neurodegeneration to cancer. FASEB J. 28:1965-74.
5. Barber GN, Jagus R, Meurs EF, Hovanessian AG, Katze MG. (1995) Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferoninduced enzyme RNA-dependent protein kinase. J. Biol. Chem. 270:17423-8.
6. Yim HC, Williams BR. (2014) Protein kinase R and the inflammasome. J. Interferon Cytokine Res. 34:447-54.
7. He Y, Franchi L, Nunez G. (2013) The protein kinase PKR is critical for LPS-induced iNOS production but dispensable for inflammasome activation in macrophages. Eur. J. Immunol. 43:1147-52.
8. Nakamura T, et al. (2010) Double-stranded RNAdependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell. 140:338-48.
9. Carvalho-Filho MA, et al. (2012) Double-stranded RNA-activated protein kinase is a key modulator of insulin sensitivity in physiological conditions and in obesity in mice. Endocrinology. 153:5261-74.
10. Carvalho BM, et al. (2013) Modulation of doublestranded RNA-activated protein kinase in insulin sensitive tissues of obese humans. Obesity (Silver Spring). 21:2452-7.
11. Nakamura T, Arduini A, Baccaro B, Furuhashi M, Hotamisligil GS. (2014) Small-molecule inhibitors of PKR improve glucose homeostasis in obese diabetic mice. Diabetes. 63:526-34.
12. Chen SS, et al. (2014) Activation of double-stranded RNA-dependent protein kinase inhibits proliferation of pancreatic beta-cells. Biochem. Biophys. Res. Commun. 443:814-20.
13. Lundh M, Scully SS, Mandrup-Poulsen T, Wagner BK. (2013) Small-molecule inhibition of inflammatory beta-cell death. Diabetes Obes. Metab. 15 Suppl 3:176-84.
14. Gil J, et al. (2004) TRAF family proteins link PKR with NF-kappa B activation. Mol. Cell. Biol. 24:4502-12.
15. Oganesyan G, et al. (2006) Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response. Nature. 439:208-11.
16. Sadler AJ, Williams BR. (2007) Structure and function of the protein kinase R. Curr. Top. Microbiol. Immunol. 316:253-92.
17. Li S, et al. (2006) Molecular basis for PKR activation by PACT or dsRNA. Proc. Natl. Acad. Sci. U. S. A. 103:10005-10.
18. Bradley JR, Pober JS. (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene. 20:6482-91.
19. Xie P. (2013) TRAF molecules in cell signaling and in human diseases. J. Mol. Signal 8:7.
20. Ogolla PS, et al. (2013) The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen. PLoS Pathog. 9:e1003557.
21. Jackson-Bernitsas DG, et al. (2007) Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene. 26:1385-97.
22. Ung TL, Cao C, Lu J, Ozato K, Dever TE. (2001) Heterologous dimerization domains functionally substitute for the double-stranded RNA binding domains of the kinase PKR. EMBO J. 20:3728-37.
23. Wang Y, et al. (2013) Elevated toll-like receptor 3 inhibits pancreatic beta-cell proliferation through G1 phase cell cycle arrest. Mol. Cell. Endocrinol. 377:112-22.
24. Institute of Laboratory Animal Resources (U. S.), Committee on Care and Use of Laboratory Animals. (1985) Guide for the Care and Use of Laboratory Animals. Rev. 1985. Bethesda (MD): NIH. 83 pp. (NIH publication; no. 85-23).
25. Han X, Sun Y, Scott S, Bleich D. (2001) Tissue inhibitor of metalloproteinase-1 prevents cytokinemediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes. 50:1047-55.
26. Kang HC, Bae YH. (2009) Transfection of rat pancreatic islet tissue by polymeric gene vectors. Diabetes Technol. Ther. 11:443-9.
27. Gu L, et al. (2013) Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi. J. Neuroinflammation. 10:109.
28. Meng ZX, et al. (2009) Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Diabetologia. 52:125-35.
29. Hu W, et al. (2009) Double-stranded RNAdependent protein kinase-dependent apoptosis induction by a novel small compound. J. Pharmacol. Exp. Ther. 328:866-72.
30. Hu Y, Conway TW. (1993) 2-Aminopurine inhibits the double-stranded RNA-dependent protein kinase both in vitro and in vivo. J. Interferon. Res. 13:323-8.
31. Ackermann AM, Gannon M. (2007) Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J. Mol. Endocrinol. 38:193-206.
32. Wang HL, et al. (2014) Mangiferin facilitates islet regeneration and beta-cell proliferation through upregulation of cell cycle and beta-cell regeneration regulators. Int. J. Mol. Sci. 15:9016-35.
33. Takada Y, et al. (2007) Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation. Oncogene. 26:1201-12.
34. Karslioglu E, et al. (2011) CMyc is a principal upstream driver of beta-cell proliferation in rat insulinoma cell lines and is an effective mediator of human beta-cell replication. Mol. Endocrinol. 25:1760-72.
35. Gao Y, et al. (2012) PERK is required in the adult pancreas and is essential for maintenance of glucose homeostasis. Mol. Cell. Biol. 32:5129-39.
36. Bourgarel-Rey V, et al. (2001) Involvement of nuclear factor kappaB in c-Myc induction by tubulin polymerization inhibitors. Mol. Pharmacol. 59:1165-70.
37. Visconti R, et al. (1997) Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene. 15:1987-94.
38. Kataoka Y, Murley JS, Khodarev NN, Weichselbaum RR, Grdina DJ. (2002) Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine. Int. J. Radiat. Oncol. Biol. Phys. 53:180-9.
39. Ghashghaeinia M, et al. (2011) The NF. B pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated erythrocytes. Cell. Physiol. Biochem. 27:45-54.
40. Liu SY, et al. (2011) Lipopolysaccharide-enhanced early proliferation of insulin secreting NIT-1 cell is associated with nuclear factor-kappaB-mediated inhibition of caspase 3 cleavage. Chin. Med J. (Engl.) 124:3652-6.
41. Xu H, You M, Shi H, Hou Y. (2014) Ubiquitinmediated NFkappaB degradation pathway. Cell Mol. Immunol. 2014, Oct 27 [Epub ahead of print].
42. Schmid JA, Birbach A. (2008) IkappaB kinase beta (IKKbeta/IKK2/IKBKB)-a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev. 19:157-65.
43. Takeuchi M, Rothe M, Goeddel DV. (1996) Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 271:19935-42.
44. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. (2006) Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell. 22:245-57.
45. Habelhah H. (2010) Emerging complexity of protein ubiquitination in the NF-kappaB pathway. Genes Cancer. 1:735-47.
46. Poitout V. (2008) Glucolipotoxicity of the pancreatic beta-cell: myth or reality? Biochem. Soc. Trans. 36:901-4.
47. Somesh BP, et al. (2013) Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity. BMC Cell. Biol. 14:31.
48. Kim JW, Yoon KH. (2011) Glucolipotoxicity in pancreatic beta-Cells. Diabetes Metab. J. 35:444-50.
49. Poitout V, Robertson RP. (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr. Rev. 29:351-66.
50. Garcia-Elorriaga G, et al. 2012. Pro-inflammatory cytokines related to severity and mortality in type 2 diabetes patients with soft tissue infection. [Article in Spanish] Rev. Med. Inst. Mex. Seguro Soc. 50:237-41.
51. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. (2014) Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 105:141-50.
52. Kong X, et al. (2014) Glucagon-like peptide 1 stimulates insulin secretion via inhibiting RhoA/ROCK signaling and disassembling glucotoxicity-induced stress fibers. Endocrinology. 155:4676-85.
53. Chang-Chen KJ, Mullur R, Bernal-Mizrachi E. (2008) Beta-cell failure as a complication of diabetes. Rev. Endocr. Metab. Disord. 9:329-43.
54. Hayes HL, et al. (2013) Pdx-1 activates islet alphaand beta-cell proliferation via a mechanism regulated by transient receptor potential cation channels 3 and 6 and extracellular signal-regulated kinases 1 and 2. Mol. Cell. Biol. 33:4017-29.
55. Chen G, Liu C, Xue Y, Mao X, Xu K. (2011) Molecular mechanism of pancreatic beta-cell adaptive proliferation: studies during pregnancy in rats and in vitro. Endocrine. 39:118-27.
56. Ishii T, Kwon H, Hiscott J, Mosialos G, Koromilas AE. (2001) Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNAbinding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR. Oncogene. 20:1900-12.
57. Bonnet MC, Weil R, Dam E, Hovanessian AG, Meurs EF. (2000) PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol. Cell. Biol. 20:4532-42.
58. Green TJ, Montagnani C. (2013) Poly I:C induces a protective antiviral immune response in the Pacific oyster (Crassostrea gigas) against subsequent challenge with Ostreid herpesvirus (OsHV-1 muvar). Fish Shellfish Immunol. 35:382-8.
59. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV. (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity. 4:387-96.
60. Li X, et al. (1999) Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Mol. Cell. Biol. 19:4643-52.
61. Kim SH, Gunnery S, Choe JK, Mathews MB. (2002) Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene. 21:8741-8.
62. Kim SH, Forman AP, Mathews MB, Gunnery S. (2000) Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene. 19:3086-94.
63. Kunkeaw N, et al. (2013) Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene. 32:3722-31.
64. Bretones G, Delgado MD, Leon J. (2015) Myc and cell cycle control. Biochim. Biophys. Acta. 1849:506-16.
65. Gil J, Alcami J, Esteban M. (1999) Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol. Cell. Biol. 19:4653-63.
66. Liuwantara D, et al. (2006) Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection. Diabetes. 55:2491-501.
67. Zhou R, et al. (2013) Blockage of progesterone receptor effectively protects pancreatic islet beta cell viability. Steroids. 78:987-95.
68. Humphrey RK, et al. (2013) Lysine 63-linked ubiquitination modulates mixed lineage kinase-3 interaction with JIP1 scaffold protein in cytokineinduced pancreatic beta cell death. J. Biol. Chem. 288:2428-40.
69. Lin WJ, et al. (2011) Crucial role for TNF receptor-associated factor 2 (TRAF2) in regulating NFkappaB2 signaling that contributes to autoimmunity. Proc. Natl. Acad. Sci. U. S. A. 108:18354-9.
70. Hupalowska A, Pyrzynska B, Miaczynska M. (2012) APPL1 regulates basal NF-kappaB activity by stabilizing NIK. J. Cell Sci. 125:4090-102.
71. Jin HR, Jin X, Dat NT, Lee JJ. (2011) Cucurbitacin B suppresses the transactivation activity of RelA/p65. J. Cell. Biochem. 112:1643-50.
72. Doppler H, Liou GY, Storz P. (2013) Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity. PloS One. 8:e53676.
73. Sun LL, et al. (2014) Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2. Oncol. Rep. 31:2085-92.
74. Mahul-Mellier AL, et al. (2012) De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF. Cell Death Differ. 19:891-9.
75. O'Donnell MA, Hase H, Legarda D, Ting AT. (2012) NEMO inhibits programmed necrosis in an NFkappaB-independent manner by restraining RIP1. PloS One. 7:e41238.
76. Ozcan U, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 306:457-61.
77. Tran K, et al. (2014) Identification of small molecules that protect pancreatic beta cells against endoplasmic reticulum stress-induced cell death. ACS Chem. Biol. 9:2796-806.
78. Pelengaris S, Khan M. (2003) The many faces of c-MYC. Arch. Biochem. Biophys. 416:129-36.
79. Pelengaris S, Khan M, Evan GI. (2002) Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell. 109:321-34.